To access this element change to forms mode OFF
Grant Award View - GA52645
Personalised targeted therapy for adolescent and young adult...
GA ID:
GA52645
Agency:
Cancer Australia
Approval Date:
26-Jun-2019
Publish Date:
2-Jul-2019
Category:
Cancer
Grant Term:
30-Jun-2019 to 29-Jun-2022
Value (AUD):
$167,168.50
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
CA 18/19 Improved cancer control
Grant Program:
2018 Priority-driven Collaborative Cancer Research Scheme
Grant Activity:
Personalised targeted therapy for adolescent and young adult medulloblastoma patients
Purpose:
Medulloblastoma is the most common malignant brain tumour of childhood but can also occur in older adolescents and young adults (AYA). The best treatment for these older patients is unknown, and until now their treatment has been suboptimal. This study will be the first of its kind in this patient group. This trial will give these patients access to state-of-the-art tumour profiling and targeted therapies in order to ensure optimal treatments to both improve cure rates, reduce therapy-related toxicities.
GO ID:
GO Title:
2018 PdCCRS Project Grants for funding commencing 2019
Internal Reference ID:
2018 PdCCRS
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
No
Confidentiality - Outputs:
No
Grant Recipient Details
Recipient Name:
University of Sydney
Recipient ABN:
15 211 513 464
Grant Recipient Location
Suburb:
Sydney
Town/City:
Sydney
Postcode:
2006
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
National
Postcode:
Multiple
Country:
AUSTRALIA